The seemingly inefficient process of tau ubiquitination and proteasome degradation, together with accumulated ubiquitinated tau in PHFs and NFTs from AD and FTD brain, has led to the argument that the proteasome has little influence on tau degradation [182,183,184,185]. Here, MAPT is linked to Alzheimer disease.